Literature DB >> 19555859

Diagnosis and assessment of pulmonary arterial hypertension.

David B Badesch1, Hunter C Champion2, Miguel Angel Gomez Sanchez3, Marius M Hoeper4, James E Loyd5, Alessandra Manes6, Michael McGoon7, Robert Naeije8, Horst Olschewski9, Ronald J Oudiz10, Adam Torbicki11.   

Abstract

The diagnosis and assessment of pulmonary arterial hypertension is a rapidly evolving area, with changes occurring in the definition of the disease, screening and diagnostic techniques, and staging and follow-up assessment. The definition of pulmonary hypertension has been simplified, and is now based on currently available evidence. There has been substantial progress in advancing the imaging techniques and biomarkers used to screen patients for the disease and to follow up their response to therapy. The importance of accurate assessment of right ventricular function in following up the clinical course and response to therapy is more fully appreciated. As new therapies are developed for pulmonary arterial hypertension, screening, prompt diagnosis, and accurate assessment of disease severity become increasingly important. A clear definition of pulmonary hypertension and the development of a rational approach to diagnostic assessment and follow-up using both conventional and new tools will be essential to deriving maximal benefit from our expanding therapeutic armamentarium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19555859     DOI: 10.1016/j.jacc.2009.04.011

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  315 in total

1.  Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

Authors:  Athénaïs Boucly; Jason Weatherald; Laurent Savale; Xavier Jaïs; Vincent Cottin; Grégoire Prevot; François Picard; Pascal de Groote; Mitja Jevnikar; Emmanuel Bergot; Ari Chaouat; Céline Chabanne; Arnaud Bourdin; Florence Parent; David Montani; Gérald Simonneau; Marc Humbert; Olivier Sitbon
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil.

Authors:  Haidong Huang; Paul Zarogoulidis; Sofia Lampaki; John Organtzis; Dimitris Petridis; Konstantinos Porpodis; Antonis Papaiwannou; Vasilis Karageorgiou; Georgia Pitsiou; Ioannis Kioumis; Wolfgang Hohenforst-Schmidt; Qiang Li; Kaid Darwiche; Lutz Freitag; Aggeliki Rapti; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

3.  The role of distress in uptake and response to predisposition genetic testing: the BMPR2 experience.

Authors:  Diana L Jones; Ellen W Clayton
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-15

4.  Assessing response to therapy in idiopathic pulmonary arterial hypertension: a consensus survey of Canadian pulmonary hypertension physicians.

Authors:  Adrienne E Borrie; David N Ostrow; Robert D Levy; John R Swiston
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

Review 5.  Redefining the role of cardiovascular imaging in patients with pulmonary arterial hypertension.

Authors:  Benjamin H Freed; Amit R Patel; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

6.  Early recognition and management of pulmonary arterial hypertension: a case for profiling.

Authors:  Kalyan Kosuri; Ghulam Saydain
Journal:  Oman Med J       Date:  2012-01

7.  Outcomes in elderly intensive care unit patients, pulmonary hypertension in sickle cell disease, and total liquid ventilation for therapeutic hypothermia after cardiac arrest in rabbits.

Authors:  Nathan E Brummel; Meredith E Pugh; Joshua P Fessel
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

Review 8.  [Management of patients with pulmonary hypertension].

Authors:  B Preckel; S Eberl; J Fräßdorf; M W Hollmann
Journal:  Anaesthesist       Date:  2012-07       Impact factor: 1.041

Review 9.  Lung involvement in systemic sclerosis.

Authors:  Paul M Hassoun
Journal:  Presse Med       Date:  2010-12-30       Impact factor: 1.228

Review 10.  The role of imaging in pulmonary hypertension.

Authors:  Meenal Sharma; Andrew T Burns; Kelvin Yap; David L Prior
Journal:  Cardiovasc Diagn Ther       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.